Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects
- PMID: 35715947
- DOI: 10.1111/apt.17091
Salivary microbiota composition may discriminate between patients with eosinophilic oesophagitis (EoE) and non-EoE subjects
Abstract
Background: Data on the role of the microbiome in adult patients with eosinophilic oesophagitis (EoE) are limited.
Aims: To prospectively collect and characterise the salivary, oesophageal and gastric microbiome in patients with EoE, further correlating the findings with disease activity.
Methods: Adult patients with symptoms of oesophageal dysfunction undergoing upper endoscopy were consecutively enrolled. Patients were classified as EoE patients, in case of more than 15 eosinophils per high-power field, or non-EoE controls, in case of lack of eosinophilic infiltration. Before and during endoscopy, saliva, oesophageal and gastric fundus biopsies were collected. Microbiota assessment was performed by 16 s rRNA analysis. A Sparse Partial Least Squares Discriminant Analysis (sPLS-DA) was implemented to identify biomarkers.
Results: Saliva samples were collected from 29 EoE patients and 20 non-EoE controls;, biopsies from 25 EoE and 5 non-EoE controls. In saliva samples, 23 Amplicon Sequence Variants (ASVs) were positively associated with EoE and 27 ASVs with controls, making it possible to discriminate between EoE and non-EoE patients with a classification error (CE) of 24%. In a validation cohort, the accuracy, sensitivity, specificity, positive predictive value and negative predictive value of this model were 78.6%, 80%, 75%, 80% and 60%, respectively. Moreover, the analysis of oesophageal microbiota samples observed a clear microbial pattern able to discriminate between active and inactive EoE (CE = 8%).
Conclusion: Our preliminary data suggest that salivary metabarcoding analysis in combination with machine learning approaches could become a valid, cheap, non-invasive test to segregate between EoE and non-EoE patients.
© 2022 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.
Comment in
-
Editorial: non-invasive testing for EoE-does microbiome testing hold the key? Authors' reply.Aliment Pharmacol Ther. 2022 Aug;56(4):729-730. doi: 10.1111/apt.17144. Aliment Pharmacol Ther. 2022. PMID: 35879893 No abstract available.
-
Editorial: non-invasive testing for EoE-does microbiome testing hold the key?Aliment Pharmacol Ther. 2022 Aug;56(4):727-728. doi: 10.1111/apt.17130. Aliment Pharmacol Ther. 2022. PMID: 35879898 No abstract available.
References
REFERENCES
-
- Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154(2):319-332.e3. https://doi.org/10.1053/j.gastro.2017.06.067
-
- Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679-92. https://doi.org/10.1038/ajg.2013.71
-
- Torrijos EG, Gonzalez-Mendiola R, Alvarado M, et al. Eosinophilic esophagitis: review and update. Front Med. 2018;(5):1-15. https://doi.org/10.3389/fmed.2018.00247
-
- Soon IS, Butzner JD, Kaplan GG, Debruyn JCC. Incidence and prevalence of eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2013;57(1):72-80. https://doi.org/10.1097/MPG.0b013e318291fee2
-
- O'Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154(2):333-45. https://doi.org/10.1053/j.gastro.2017.06.065
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical